Trial Profile

A Cohort Dose-Escalation Phase 1 Study of Intramuscular Injection of Uricase-PEG 20

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 08 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pegadricase (Primary)
Indications Gout; Hyperuricaemia
Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics

Most Recent Events

08 Aug 2014 Status changed from recruiting to completed, according to a 3SBio media release.
24 Feb 2010 New trial record.
23 Feb 2010 Results are expected later in 2010.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com